Recently, Russian television station RT reported that although research on the effects of e-cigarettes on the human body is not yet fully clear, doctors have already sounded the alarm about possible risks of lung and oral cancers. Dr. Anastasia Maryenko, a manager in European oncology, issued this warning during an interview with RT.
Anastasia explained that cigarette smoke contains a large amount of free radicals, which, when entering the respiratory system, can disrupt the balance of antioxidants in the human body. This can potentially lead to the release of inflammatory mediators and the damage of lung tissue cell membranes. "This damage can have serious consequences, promoting chronic respiratory diseases such as chronic obstructive pulmonary disease and lung cancer, all of which also apply to e-cigarettes," warned experts.
While some may perceive the ingredients of e-cigarette liquid to be harmless, the reality is quite the opposite. When heated, these substances can transform into compounds that have the potential to damage DNA and facilitate the development of cancer. What is even more concerning is that, due to the absence of filters in e-cigarettes, a greater amount of harmful substances enters the body when they are used, added Anastasia.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
